Skip to main content
Download PDF

Posttraumatic stress disorder and depression of survivors 12 months after the outbreak of Middle East respiratory syndrome in South Korea

BMC Public Health volume 20, Article number: 605 (2020) Cite this article

Abstract

Background

The 2015 outbreak of Middle East Respiratory Syndrome (MERS) in the Republic of Korea is a recent and representative occurrence of nationwide outbreaks of Emerging Infectious Diseases (EIDs). In addition to physical symptoms, posttraumatic stress disorder (PTSD) and depression are common following outbreaks of EID.

Methods

The present study investigated the long-term mental health outcomes and related risk factors in survivors of MERS. A prospective nationwide cohort study was conducted 12 months after the MERS outbreak at multi-centers throughout Korea. PTSD and depression as the main mental health outcomes were assessed with the Impact of Event Scale-Revised Korean version (IES-R-K) and the Patient Health Questionnaire-9 (PHQ-9) respectively.

Results

42.9% of survivors reported PTSD (IES-R-K ≥ 25) and 27.0% reported depression (PHQ-9 ≥ 10) at 12 months post-MERS. A multivariate analysis revealed that anxiety (adjusted odds ratio [aOR], 5.76; 95%CI, 1.29–25.58; P = 0.021), and a greater recognition of stigma (aOR, 11.09, 95%CI, 2.28–53.90; P = 0.003) during the MERS-affected period were independent predictors of PTSD at 12 months after the MERS outbreak. Having a family member who died from MERS predicted the development of depression (aOR, 12.08, 95%CI, 1.47–99.19; P = 0.020).

Conclusion

This finding implies that psychosocial factors, particularly during the outbreak phase, influenced the mental health of patients over a long-term period. Mental health support among the infected subjects and efforts to reduce stigma may improve recovery from psychological distress in an EID outbreak.

Peer Review reports

Background

The 2015 outbreak of the Middle East Respiratory Syndrome coronavirus (MERS-CoV) in the Republic of Korea had an enormous impact on medical, psychological, and social issues nationwide [1]. The outbreak lasted from May 2015 to Dec. 2015 and resulted in 186 infected patients within the initial 2 months, 16,693 officially isolated individuals, and an overall mortality of 38 patients in a total of 50 million population [2]. Acute infectious outbreaks of Emerging Infectious Diseases (EIDs) are known to influence the physical as well as the mental health of affected patients, as observed during similar events such as the Severe Acute Respiratory Syndrome (SARS) outbreak [3], which was associated with such issues during the acute phase [4] and the long-term follow-up phase [5, 6]. 35% of 425 survivors expressed anxiety or depressive symptoms at 1-month post-SARS in Hong Kong where 1755 citizens were infected, and its fatality was 17.0% [4]. In ninety survivors’ cohort study for 30 months in Hong Kong, post-SARS cumulative incidence of psychiatric disorders was 58.9%. The most common diagnoses were PTSD (25.6%) and depression (13.3%) [5].

Few studies have investigated the psychological impact of the 2015 Korean MERS-CoV outbreak, but a survey conducted during this period found that 90% of the general public reported worrying about being infected by MERS-CoV and that 46% of this population experienced psychological distress [7]. Another study reported that 7.6% of 1656 isolated individuals exhibited anxiety symptoms and that 16.6% of this group reported feelings of anger during the isolation period [8]. In contrast, anxiety was present in 47.2% of MERS patients [8], which was more prevalent than the rate of anxiety in isolated people without the MERS-CoV infection. Compared to patients with other diseases, those with EIDs may experience greater suffering in terms of the physical and psychiatric symptoms of the infectious illness itself [9]; extreme fear and anxiety due to their unfamiliarity with the disease, which may be life-threatening [10]; abrupt isolation from family and society during the illness [8]; stigma due to the infectious disease [11]; the unexpected death of a family member; and/or social impairments [12].

Given that some factors, such as grief or stigma, may be persistent following the MERS illness, the suffering of afflicted individuals may negatively influence recovery in their daily lives during the acute outbreak period as well as the post-MERS period. Studies of SARS survivors in Hong Kong and China reported persistent psychological burdens, including post-traumatic stress disorder (PTSD), in over 40% of the survivors after 3 years [13]. However, no studies have investigated the mental health status of MERS survivors. Thus, the present study explored mental health issues and related factors in MERS survivors 12 months after the outbreak to determine the long-term psychological outcomes of this population.

Methods

Study design

The present study was part of a prospective nationwide cohort study of MERS survivors conducted at multi-centers in the Republic of Korea. For purposes of this study, a MERS survivor was defined as a patient who was diagnosed with the MERS-CoV infection and then completely recovered, as confirmed by the Korean government during the 2015 outbreak. Of 148 MERS survivors who were eligible, 73 consented to participate in the study initially when they were contacted by phone and mail at 6 months post-MERS (Fig. 1). Of these participants, 69 survivors completed the 12-month assessment that consisted of medical tests between June 2016 and August 2016. Among them, 63 participants provided consent to participate in the psychological assessments in five tertiary hospitals: National Medical Center, Seoul National University Hospital, Chungnam National University Hospital, Seoul Medical Center, and Dankook University Hospital. All subjects were older than 19 years of age at enrollment, voluntarily participated in the study, and answered the questionnaires independently. Written informed consent was obtained from all subjects, and the study was approved by the Institutional Review Board of each study hospital.

Fig. 1
figure 1

Recruitment of participants in survivors of the MERS outbreak in South Korea

Full size image

Measures

All subjects responded to self-report questionnaires assessing sociodemographic characteristics, previous history of medical illness or psychiatric visit, illness experiences during the MERS-CoV infection period, and psychological features. Questions about MERS-related illness experiences solicited information regarding status during infection, duration of hospitalization, presence of pneumonia, whether a ventilator or extracorporeal membrane oxygenation was applied, and whether a family member died from MERS.

To determine psychological outcomes, PTSD was assessed with the Impact of Event Scale-Revised Korean version (IES-R-K) [14, 15], and depression was evaluated with the Patient Health Questionnaire-9 (PHQ-9) [16, 17]. The IES-R-K is a 22-item scale that assesses symptoms of intrusion, avoidance and numbing, and hyperarousal related to a particular life-threatening event (i.e., MERS-CoV infection in the present study). Each item is rated on a scale ranging from 0 to 4, and a total score ≥ 25 is considered to be clinically significant [15]. The PHQ-9 is a nine-item scale that assesses depression based on the symptoms of major depressive disorder included in the Diagnostic and Statistical Manual of Mental Disorders-fourth edition (DSM-IV) [16]. Significant depression is considered to be present when the total score is > 10 [17].

Current suicidality was assessed with the suicidality module of the Mini-International Neuropsychiatric Interview (K-MINI) [18, 19], which is composed of six weighted items rated as ‘yes’ or ‘no’: wish for death (weight of 1), wish for self-harm (weight of 2), suicidal thoughts (weight of 6), suicide plan (weight of 10), suicide attempt in the past 1 month (weight of 10), and lifetime suicide attempt (weight of 4). The suicidality score is the sum of the weighted score of the six items, and a total score ≥ 6 is considered to be above moderate degree of risk. Anxiety was assessed with the Generalized Anxiety Disorder-7 (GAD-7) scale, which consists of seven items rated using a four-point Likert scoring system [20]. A total score ≥ 10 is considered to be significant. The PHQ-9 and the GAD-7 were administered additionally at two points, before and during infection with MERS-CoV, based on participant recall.

Insomnia was evaluated with the Korean version of the Insomnia Severity Index (ISI-K) [21], a five-item measure relying on a five-point scale that assesses current sleep problems and interference with daily functioning; clinical insomnia was considered to be present if the total score was ≥15. MERS stigma was assessed with an adjusted version of the 40-item Berger Human Immunodeficiency Virus (HIV) stigma scale [22] and the 8-item short version of the HIV stigma scale [23]. This questionnaire contains eight items rated on a four-point Likert-type scale that ranges from “strongly disagree” to “strongly agree” and assesses the four domains of stigma: personalized stigma, disclosure concerns, negative self-image, and concerns with public attitudes; the Cronbach’s α in the present study was 0.919. The present study also included the Brief COPE, which is a 28-item questionnaire that uses a four-point Likert scale to measure three distinctive coping strategies: emotion-focused, problem-focused, and dysfunctional [24]. The social support systems of participants were assessed with the Medical Outcome Study Social Support Survey (MOS-SSS) [25], which includes 19 items that are scored on a scale from 0 to 100 and assesses emotional/information support, tangible support, positive social interactions, and affectionate support. To examine the impact of social support on mental health in a regression analysis, poor social support was defined as a MOS-SSS score lower than that of the 25th percentile for all participants.

Statistical analysis

The sociodemographic characteristics, MERS-related clinical characteristics, and mental health status of the participants are presented as both numerical values and percentages. The present study placed a particular focus on PTSD and depression, which were the two most prevalent problems 12 months post-MERS in the descriptive analysis. Accordingly, the subjects were divided into two groups based on the presence of significant PTSD or depression. Independent t-tests were conducted to compare the mental health status between the two groups (P < 0.002, adjusted for multiple comparisons), a stepwise regression analysis was performed to identify independent risk factors for PTSD and depression at 12 months after the MERS outbreak, and a univariate analysis was used to identify potential mediating factors associated with PTSD/depression (P < 0.10). Subsequently, a backward multivariate logistic regression analysis was performed using variables identified as significant in the univariate analysis (P < 0.05). Although depression during MERS and current MERS stigma were significant in the univariate analysis, these variables were not entered into the multivariate regression analysis due to multicollinearity with anxiety during MERS (r = 0.831, P < 0.001) and MERS stigma during MERS (r = 0.628, P < 0.001), respectively. All data were analyzed with SPSS for Windows version 21.0 (IBM Corp.; Armonk, NY, USA) except for the multivariate logistic regression analysis, which was performed with STATA version 14.0 (STATA; College Station, TX, USA).

Results

The demographic characteristics of the subjects are presented in Table 1. Although more male (n = 39, 61.9%) than female subjects were included in the study, the age distribution was relatively even (mean age: 49.2 years, standard deviation [SD]: 12.6). Of the 63 subjects, 15.9% had a history of a visit to a psychiatric clinic prior to the MERS outbreak. The distribution of respondents at the point of MERS-CoV infection was as follows: patients, 31.7%; healthcare providers, 23.8%; caregivers, 17.5%; and those visiting the patients in hospitals, 17.5% (Table 2). The median length of hospitalization was 21 days (range: 7–120 days), 33% of survivors had pneumonia, 19% received ventilator treatment during MERS, 12.7% had a family member who died from MERS, and 66.7% received financial support.

Table 1 Sociodemographic characteristics of participants in MERS survivors, South Korea
Full size table
Table 2 MERS-related clinical information and experiences of participants in MERS survivors, South Korea
Full size table

Overall, 54% of the subjects had at least one symptom of PTSD, depression, suicidality, or insomnia that was significantly above the clinical threshold. The mean total score on the IES-R was 25.93 (SD = 20.01), and 42.9% of the subjects had significant PTSD (Table 3). The mean score on the PHQ-9 was 2.49 (SD = 3.53) before infection with MERS-CoV, 13.54 (SD = 8.80) during the infection, and 6.60 (SD = 6.2) at 12 months after the initial infection. Moreover, 27% of the subjects had depression at 12 months post-MERS. Most subjects had a minimum risk of suicidality, but 22.2% showed at least a moderate degree of suicidal risk. Of the survivors, 28% reported significant insomnia at 12 months after the MERS outbreak. During MERS and 12 months post-MERS, all domains of PTSD, anxiety, and depression were more severe, and the quality of life was worse in survivors with current PTSD or depression compared to those without PTSD or depression (P < 0.001) (Table S1). However, anxiety and depression prior to MERS did not significantly differ in either comparison. Survivors with PTSD reported higher scores for negative coping strategies compared to those without PTSD (P = 0.001).

Table 3 Mental health status of participants in MERS survivors, South Korea
Full size table

Univariate and multivariate logistic regression analyses were performed to identify risk factors associated with PTSD or depression at 12 months post-MERS. The univariate analysis revealed that several factors were significantly associated with PTSD, including previous psychiatry history, having a family member who died from MERS, depression and anxiety during the MERS-affected period, greater perceived stigma currently and during the illness, and negative coping strategies (Table S2). Depression was associated with gender, previous psychiatry history, anxiety before MERS, having a family member who died from MERS, and depression, anxiety, and greater stigma during the affected phase. Neither the severity of MERS nor complications, such as the development of pneumonia, use of a ventilator, or extracorporeal membrane oxygenation was associated with PTSD or depression. Likewise, not having a spouse, living with a child, and poor social support were not associated with these outcomes.

The multivariate logistic regression analysis revealed that previous psychiatric history (adjusted odds ratio [aOR]: 9.09, 95% confidence interval [CI]: 1.05–78.67; P = 0.045), anxiety (aOR: 5.76, 95% CI: 1.29–25.58; P = 0.021), and greater recognition of stigma (aOR: 11.09, 95% CI: 2.28–53.90; P = 0.003) during the MERS-affected period were independent predictors of PTSD at 12 months after MERS (Table 4). Additionally, previous psychiatric history (aOR: 9.97, 95% CI: 1.53–65.11; P = 0.016) and having a family member who died from MERS (aOR: 12.08, 95% CI: 1.47–99.19; P = 0.020) predicted the development of depression at this timepoint.

Table 4 Multivariate analysis assessing PTSD and depression and related variables 12 months after the MERS outbreak, South Korea
Full size table

Discussion

The MERS outbreak in 2015 is a noteworthy example of a national disaster that impacted most Korean people. Its early and rapid dissemination via hospitals concentrated in metropolitan areas [2], high fatality rate of nearly 20% [2], and unfamiliarity as a novel infectious disease [26] may have led to high levels of anxiety and fear about being infected among the public and about death among affected people [7]. The present findings confirmed high prevalence of mental health problems in survivors at the recovery phase after the outbreak.

The prevalence of PTSD in survivors at 12 months post-MERS in the present study was comparable to the rate of 41.7% observed in a study of 63 SARS survivors at 3 months post-discharge from a hospital in Singapore [27] and higher or comparable to the rates of PTSD in patients with HIV (30–35%), adult survivors of a human-made disaster (30–60%) [28], and survivors of a stay in an intensive care unit (14–59%) [29, 30]. This indicates that an EID is not only a serious medical illness but also a psychologically traumatic experience for patients that can result in long-term psychological burdens. Additionally, the result suggests that mental health problems caused by an EID outbreak can continue for a long period. For example, another study showed that 42.5% of SARS survivors in Hong Kong still showed active psychiatric illnesses at 3 years post-SARS infection [31]. Furthermore, a second study demonstrated that 42% of Chinese SARS survivors still experienced PTSD at 4 years post-SARS [13]. Assuming that the experiences of the patients in the MERS outbreak are similar in terms of EIDs, the mental health problems of the MERS survivors in the present study may persist for longer than 12 months. Therefore, a study on mental health outcomes after 12 months post-MERS will be required.

Of the premorbid characteristics of the subjects, only a history of a visit to a psychiatric clinic was independently related to PTSD and depression at 12 months post-MERS, whereas demographic factors, such as gender, age, and level of education were not. On the other hand, high anxiety levels, perceived stigma about MERS, and having a family member who died from MERS predicted the development of PTSD or depression. These findings indicate that the psychological outcomes associated with an EID are mainly affected by factors during the outbreak period. Furthermore, the presence of a physical illness prior to the MERS-CoV infection and the severity of MERS were not associated with PTSD or depression. Thus, psychosocial factors, rather than medical factors, may play an important role during MERS-CoV infection in terms of mental health status. These findings differ from those of a study investigating SARS survivors at 30 months post-infection, which found that the risk factors of PTSD included being female, the pre-SARS presence of chronic medical illness, and the presence of complications caused by SARS treatment [32]. It is possible that the relatively small sample size of the present study was insufficient to statistically identify the influences of demographic characteristics and medical severity on adverse psychological outcomes. However, psychological burdens, such as widespread and extreme fear or feelings of isolation caused by MERS [7], may have outweighed the possible contributions of these other factors. A previous report showing that only a history of mental disease and financial burden are related to anxiety in MERS patients [8] supports this assumption.

The present findings suggest a need for appropriate psychosocial support during infectious outbreaks to reduce psychological distress in patients [1]. Therefore, healthcare professionals who treat these patients should be aware of the risk of developing adverse psychological outcomes during the acute stage of the illness as well as during the follow-up period. In particular, patients with a prior psychiatric history, high levels of psychological distress during the illness, or a negative perception about MERS should be given more attention. Interestingly, on our univariate analysis, we can assume that negative coping strategy such as denial, substance use, and self-blame may affect the development of PTSD. This relationship between negative coping style and PTSD is consistent with the previous findings in natural disaster and infectious disease [33, 34]. It suggests that providing what is a useful coping strategy should be included in psychosocial support for survivors from EID.

Similarly, the governmental strategy for the management of EIDs should include psychosocial support based on group characteristics, risk factors, and severity of distress. The White Paper, ‘MERS 2015,’ issued by the Korean government proposed that the national policy for EIDs should include content for “improving ethical problems and strengthening psychological support in EID control.” [1] The present findings suggest several considerations in this regard. In general, during the early outbreak phase, it is important that effective risk communication is incorporated into the overall strategy to reduce fear among the general public and quarantined people [35]; when developing such a strategy for this phase, it is also important to consider the ethical issues related to patients and quarantined people to minimize stigma [36]. More specifically, due to the high prevalence of mental health problems, routine care for EID patients should include effective psychological support that reflects individual risk factors and the current level of distress. In fact, the central and local Korean governments provided psychological support for quarantined people, patients, and families who had a member die from MERS using designated public mental health care centers and telephone counseling during the outbreak [1]. The core value associated with this program was adequate public accessibility; indeed, rather than rely on the passive provision of information, the program was implemented in a proactive manner [37].

In addition, we should pay attention to stigma as a risk factor amenable to change rather than other psychosocial variables for PTSD in the study. In EID outbreak, the perspective is easily made that an infected patient is regarded as a dangerous vector or perpetrator to spread virus who should be isolated from the society [38]. It can be maintained even after the outbreak [39]. The stigma may produce discrimination and exclusion from a community regardless of medical indications. It would significantly threaten a patient’s mental health and social relationship. Consequently, their life could be influenced in a variety of domains such as residence, occupation and the use of healthcare for a long time [40]. This study showed that reducing stigma can be an effective strategy to ameliorate psychological consequence after an EID. Media and government should respect a patient or quarantined people as a citizen who are suffering and be sensitive to words or actions that might stigmatize a specific person or group. A community and healthcare service need to provide active support for an isolated patient to relieve their burden from the stigma [41].

The present study has several limitations that should be noted. Because this study assessed only 43% of the overall MERS survivors, the results may not reflect the status of all survivors. However, the distributions of the demographic data on age, gender, and area of residence in the present study were similar to those in the official reports for all MERS patients [1]. Second, psychological distress and stigma during the pre-MERS period and during the MERS-CoV infection were evaluated based on participant recall and may not accurately represent the actual status of the subjects. Additionally, the relatively small sample size may have limited the ability to identify risk factors due to low statistical power. However, given that 47.2% of 34 patients reported anxiety using the same scale in a previous study conducted during the isolation period [8], it can be assumed that the subjects in the present study were not likely to overestimate their symptoms during recall. Finally, we assessed only with self-questionnaire that could be considered less accurate than the ratings of a clinician.

Conclusions

Our study showed that nearly half the assessed MERS survivors experienced significant mental health problems, including PTSD and depression, at 12 months post-MERS. MERS-specific psychosocial distress may influence long-term psychological sequelae. Thus, efforts to control EIDs should include all levels of government and involve the implementation of effective strategies to reduce fear and stigma among the public; they should also enable the provision of adequate psychological support and hospital care for infected people.

Availability of data and materials

The data obtained from the current study are not publicly available due to the sensitive nature of the study.

Abbreviations

DSM-IV:

Diagnostic and Statistical Manual of Mental Disorders-fourth edition

EID:

Emerging Infectious Disease

GAD-7:

Generalized Anxiety Disorder-7

HIV:

Human Immunodeficiency Virus

IES-R-K:

Impact of Event Scale-Revised Korean version

ISI-K:

Insomnia Severity Index

MOS-SSS:

Medical Outcome Study Social Support Survey

MERS-CoV:

Middle East respiratory syndrome coronavirus

PHQ-9:

Patient Health Questionnaire-9

PTSD:

posttraumatic stress disorder

SARS:

Severe Acute Respiratory Syndrome

References

  1. Korea Centers for Disease Control and Prevention. The 2015 MERS outbreak in the Republic of Korea: Learning from MERS. July, 2016 [cited 2017 Mar 15]. http://www.mers.go.kr/mers/html/jsp/main.jsp.

  2. Kim KH, Tandi TE, Choi JW, Moon JM, Kim MS. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J Hosp Infect. 2017;95:207–13.

    Article  CAS  Google Scholar 

  3. Xiang YT, Yu X, Ungvari GS, Correll CU, Chiu HF. Outcomes of SARS survivors in China: not only physical and psychiatric co-morbidities. East Asian Arch Psychiatry. 2014;24:37–8.

    CAS  PubMed  Google Scholar 

  4. Cheng SK, Wong CW, Tsang J, Wong KC. Psychological distress and negative appraisals in survivors of severe acute respiratory syndromes (SARS). Psychol Med. 2003;34:1187–95.

    Article  Google Scholar 

  5. Mak IWC, Chu CM, Pan PC, Yiu MGC, Chan VL. Long-term psychiatric morbidities among SARS survivors. Gen Hosp Psychiatry. 2009;31:318–26.

    Article  Google Scholar 

  6. Lee AM, Wong JGWS, McAlonan GM, Cheung V, Cheung C, Sham PC, et al. Stress and psychological distress among SARS survivors 1 year after the outbreak. Can J Psychiatr. 2007;52:233–40.

    Article  Google Scholar 

  7. Lee DH, Kim JY, Kang HS. The emotional distress and fear of contagion related to Middle East respiratory syndrome (MERS) on general public in Korea. Kor J Psychol: Gen. 2016;35:355–83.

    Google Scholar 

  8. Jeong H, Yim HW, Song YJ, Ki M, Min JA, Cho J, et al. Mental health status of people isolated due to Middle East respiratory syndrome. Epidemiol Health. 2016;5:e2016048.

    Article  Google Scholar 

  9. Cheng SK, Tsang JS, Ku KH, Wong CW, Ng YK. Psychiatric complications in patients with severe acute respiratory syndrome (SARS) during the acute treatment phase: a series of 10 cases. Br J Psychiatry. 2004;184:359–60.

    Article  Google Scholar 

  10. Wu KK, Chan SK, Ma TM. Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS). J Trauma Stress. 2005;18:39–42.

    Article  Google Scholar 

  11. Pappas G, Kiriaze IJ, Giannakis P, Falagas ME. Psychosocial consequences of infectious diseases. Clin Microbiol Infect. 2009;15:743–7.

    Article  CAS  Google Scholar 

  12. Wing YK, Leung CM. Mental health impact of severe acute respiratory syndrome: a prospective study. Hong Kong Med J. 2012;18(Suppl 3):24–7.

    PubMed  Google Scholar 

  13. Hong X, Currier GW, Zhao X, Jiang Y, Zhou W, Wei J. Posttraumatic stress disorder in convalescent severe acute respiratory syndrome patients: a 4-year follow-up study. Gen Hosp Psychiatry. 2009;31:546–54.

    Article  Google Scholar 

  14. Lim HK, Woo JM, Kim TS, Kim TH, Choi KS, Chung SK, et al. Reliability and validity of the Korean version of the impact of event scale-revised. Compr Psychiatry. 2009;50:385–90.

    Article  Google Scholar 

  15. Eun HJKT, Lee SM, Kim TH, Choi MR, Cho SJ. A study on reliability and validity of the Korean version of impact of event scale-revised. J Korean Neuropsychiatr Assoc. 2005;44:303–10.

    Google Scholar 

  16. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–13.

    Article  CAS  Google Scholar 

  17. An JY, Seo ER, Lim KH, Shin JH, Kim JB, Information C. Standardization of the Korean version of screening tool for depression (patient health Questionnaire-9, PHQ-9). J Korean Soc Biol Ther Psychiatry. 2013;19:47–56.

    Google Scholar 

  18. Yoo SW, Kim YS, Noh JS, Oh GS, Kim CH, NamKoong K, et al. Validity of Korean version of the Mini-international neuropsychiatric interview. Anxiety Mood. 2006;2:50–5.

    Google Scholar 

  19. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22–33;quiz 34–57.

  20. Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder. Arch Inern Med. 2006;166:1092–7.

    Google Scholar 

  21. Cho YW, Song ML, Morin CM. Validation of a Korean version of the insomnia severity index. J Clin Neurol. 2014;10:210–5.

    Article  Google Scholar 

  22. Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24:518–29.

    Article  CAS  Google Scholar 

  23. Wiklander M, Rydstrom LL, Ygge BM, Naver L, Wettergren L, Eriksson LE. Psychometric properties of a short version of the HIV stigma scale, adapted for children with HIV infection. Health Qual Life Outcomes. 2013;11:1–7.

    Article  Google Scholar 

  24. Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997;4:92–100.

    Article  CAS  Google Scholar 

  25. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32:705–14.

    Article  CAS  Google Scholar 

  26. Kim KH, Tandi TE, Choi JW, Moon JM, Kim MS. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J Hosp Infect. 2016;95:207–13.

    Article  Google Scholar 

  27. Kwek SK, Chew WM, Ong KC, Ng AW, Lee LS, Kaw G, et al. Quality of life and psychological status in survivors of severe acute respiratory syndrome at 3 months postdischarge. J Psychosom Res. 2006;60:513–9.

    Article  Google Scholar 

  28. Galea S, Nandi A, Vlahov D. The epidemiology of post-traumatic stress disorder after disasters. Epidemiol Rev. 2005;27:78–91.

    Article  Google Scholar 

  29. Tedstone JE, Tarrier N. Posttraumatic stress disorder following medical illness and treatment. Clin Psychol Rev. 2003;23:409–48.

    Article  Google Scholar 

  30. Kapfhammer HP, Rothenhäusler HB, Krauseneck T, Stoll C, Schelling G. Posttraumatic stress disorder and health-related quality of life in long-term survivors of acute respiratory distress syndrome. Am J Psychiatry. 2004;161:45–52.

    Article  Google Scholar 

  31. Lam MH, Wing YK, Yu MW, Leung CM, Ma RC, Kong AP, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169:2142–7.

    Article  Google Scholar 

  32. Mak IW, Chu CM, Pan PC, Yiu MGC, Ho SC, Chan VL. Risk factors for chronic post-traumatic stress disorder (PTSD) in SARS survivors. Gen Hosp Psychiatry. 2010;32:590–8.

    Article  Google Scholar 

  33. Cofini V, Carbonelli A, Cecilia MR, Binkin N, di Orio F. Post-traumatic stress disorder and coping in a sample of adult survivors of the Italian earthquake. Psychiatry Res. 2015;229:353–8.

    Article  CAS  Google Scholar 

  34. Olley BO, Zeier MD, Seedat S, Stein DJ. Post-traumatic stress disorder among recently diagnosed patients with HIV/AIDS in South Africa. AIDS Care. 2005;17:550–7.

    Article  CAS  Google Scholar 

  35. Ro JS, Lee JS, Kang SC, Jung HM. Worry experienced during the 2015 Middle East respiratory syndrome (MERS) pandemic in Korea. PLoS One. 2017;12:e0173234.

    Article  Google Scholar 

  36. Kim OJ. Ethical perspectives on the Middle East respiratory syndrome coronavirus epidemic in Korea. J Prev Med Public Health. 2016;49:18–22.

    Article  Google Scholar 

  37. Yoon MK, Kim SY, Ko HS, Lee MS. System effectiveness of detection, brief intervention and refer to treatment for the people with post-traumatic emotional distress by MERS: a case report of community-based proactive intervention in South Korea. Int J Ment Health Sy. 2016;10:51.

    Article  Google Scholar 

  38. Battin MP, Francis LP, Jacobson JA, Smith CB. The patient as victim and vector: ethics and infectious disease. New York: Oxford University Press; 2009.

    Book  Google Scholar 

  39. Siu JY. The SARS-associated stigma of SARS victims in the post-SARS era of Hong Kong. Qual Health Res. 2008;18:729–38.

    Article  Google Scholar 

  40. Lee S, Chan LY, Chau AM, Kwok KP, Kleinman A. The experience of SARS-related stigma at Amoy gardens. Soc Sci Med. 2005;61:2038–46.

    Article  Google Scholar 

  41. Thoits PA. Stress and health: major findings and policy implications. J Health Soc Behav. 2010;51(Suppl):S41–53.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge all the participants and researchers in the cohort study for MERS survivors.

Funding

The study was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (HI15C3227) and a grant from the Korean Mental Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HL19C0007). The funding bodies were not involved in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Author information

Authors and Affiliations

  1. Seoul National University Hospital, Seoul, Republic of Korea

    Hye Yoon Park

  2. Seoul National University College of Medicine, Seoul, Republic of Korea

    Wan Beom Park

  3. National Medical Center, 245, Eulji-ro, Jung-gu, Seoul, 04564, Republic of Korea

    So Hee Lee & Hyoung-Shik Shin

  4. Chungnam National University School of Medicine, Daejeon, Republic of Korea

    Jeong Lan Kim

  5. Dankook University School of Medicine, Cheonan, Chungnam, Republic of Korea

    Jung Jae Lee

  6. Seoul Medical Center, Seoul, Republic of Korea

    Haewoo Lee

Authors
  1. Hye Yoon Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wan Beom Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. So Hee Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jeong Lan Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jung Jae Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Haewoo Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hyoung-Shik Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SHL and HSS coordinated the overall study. HYP, SHL, JLK, JJL, HL, and HSS were involved in the concept and the design of the study. HYP and SHL undertook the statistical analysis and drafted the manuscript. HYP, WBP, SHL, JLK, JJL, HL, and HSS contributed to the acquisition and the interpretation of the data, revised the manuscript and approved the article of its final version.

Corresponding authors

Correspondence to So Hee Lee or Hyoung-Shik Shin.

Ethics declarations

Ethics approval and consent to participate

The present study protocol was reviewed and approved by the Institutional Review Board of National Medical Center (No. H-1510-059-007; 2015-10-22), Seoul National University Hospital (No. 1511–117-723; 2016-1-13), Chungnam National University Hospital (No. 2015–08–029-007; 2016-2-18), Seoul Medical Center (No. 2015–12-102; 2016-2-17), and Dankook University Hospital (No. 2016–02–014; 2016-4-8). Written informed consent was submitted by all subjects when they were enrolled.

Consent for publication

Not Applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1 Table S1.

Comparisons of mental health status and related factors between survivors with and without PTSD/depression in South Korea. Table S2. Univariate analysis assessing PTSD and depression and related variables 12 months after the MERS outbreak, in South Korea.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, H.Y., Park, W.B., Lee, S.H. et al. Posttraumatic stress disorder and depression of survivors 12 months after the outbreak of Middle East respiratory syndrome in South Korea. BMC Public Health 20, 605 (2020). https://doi.org/10.1186/s12889-020-08726-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-020-08726-1

Keywords

BMC Public Health

ISSN: 1471-2458

Contact us